Please Wait
Applying Filters...
menu
    • menu
    DMF filings hit all-time high in Q3 2024; China tops list with 58% increase in Type II submissions

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Oct 2024: Lundbeck acquires Longboard for US$ 2.6 bn; molecular glue degrader tech witnesses dealmaking

    Stock Recap
    #PipelineProspector

    Menu

    (-)-Hyoscine hydrobromide

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 7,355Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name MF Registration No. Classification Initial Date of Reg. Latest Date of Reg. Registrant's Address
    26/09/2024 ALPS Pharmaceutical Ind. Co. Ltd.
    Japan
    		 Alps Pharmaceutical Co., Ltd. 227MF10032 Japanese Pharmacopoeia Scopolamine Hydrobromide Hydrate 2015-01-23 2015-01-23 2-10-50 Mukaimachi, Furukawa-cho, Hida-shi, Gifu Prefecture
    26/09/2024 Boehringer Ingelheim GmbH
    Germany
    		 Boehringer Ingelheim Pharma GmbH & Co. K.G. 221MF10105 Scopolamine hydrobromide hydrate 2009-05-27 2009-05-27 Binger Strasse 173, 55216 Ingelheim am Rhein